Skip to main content
Clinical Trials/ACTRN12624000704594
ACTRN12624000704594Not yet recruitingUnknown

utritional milk supplementation and breastfeeding counselling for growth faltering amongst infants aged under six months in Asia and Africa

World Health Organization0 sites9,900 target enrollmentStarted: June 4, 2024Last updated:
Conditions

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Enrollment
9,900

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
7 Days to 13 Days (—)
Sex
All

Inclusion Criteria

  • Age of baby > = 7 and < 14 days
  • -Ultrasound-based gestational age before 20 weeks of gestation is available
  • -Baby is 28 weeks gestation or more
  • -Birth weight taken within 72 hours after birth
  • -Baby has been fed breastmilk at any time since birth

Exclusion Criteria

  • -The biological mother is dead at the time of screening
  • -Baby has a major abnormality or condition which is impairing feeding or nutrition (such as severe cleft palate, severe asphyxia, severe respiratory distress syndrome, need for mechanical ventilation, severe necrotising enterocolitis, major surgery)
  • -Family does not intend to live in the study area for six months
  • -The mother has given birth to three or more babies (ie twins are included but triplets or quadruplets etc are excluded)
  • -A baby from the same household is currently part of the study (i.e. is being visited by the study team).

Investigators

Similar Trials

utritional management of growth faltering... | Clinical Trial